Results for tag: "Relugolix"

Relugolix is a medication used to treat endocrine and metabolic disorders. It is a gonadotropin-releasing hormone (GnRH) receptor antagonist, which works by blocking the action of GnRH, a hormone that stimulates the production of sex hormones. This reduces the production of testosterone and estrogen, which can help treat conditions such as prostate cancer, endometriosis, and uterine fibroids. Relugolix is administered orally and is available in tablet form. The Relugolix market is composed of pharmaceutical companies that develop, manufacture, and market the drug. These companies include Myovant Sciences, AbbVie, and Takeda Pharmaceuticals. Additionally, Relugolix is also available through generic manufacturers, such as Teva Pharmaceuticals and Sandoz. Show Less Read more